NEW YORK (May 25, 2016) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced
funding for two projects leveraging the promise of engineered stem cells to speed new therapies and
deeper understanding of Parkinson’s disease.
MADISON, WIS., May 25, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an agreement with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to derive induced pluripotent stem cells (iPSCs) from 85 people in the MJFF-sponsored Parkinson’s Progression Markers Initiative (PPMI). The collaborators will provide the cells to the scientific community in concert with rich available clinical and imaging data on these study volunteers in service to their shared goal to provide resources to accelerate the development of new therapies.